📰 Memory Disorders Center News
Memory Disorders Center News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Memory Disorders Center. Real-time updates on events, politics, business and more.
May 2, 2024
Westchester Magazine celebrates these 15 outstanding people (plus canine!) who have dedicated themselves to improving quality of life.
September 1, 2023
Gothamist is a non-profit local newsroom, powered by WNYC.
July 24, 2023
The push to help people living with Alzheimer's disease is expanding. It was two weeks ago that the FDA approved Leqembi as the first treatment for the degenerative disease.
July 23, 2023
Legendary singer Tony Bennett, who died on July 21 in New York at age 96, had a history of health issues over the years, culminating in his seven-year battl ...
July 22, 2023
After singer Tony Bennett's death, several neurology experts shared with Fox News Digital what people should know about late-stage Alzheimer’s and its potentially fatal complications.
July 22, 2023
After singer Tony Bennett's death, several neurology experts shared with Fox News Digital what people should know about late-stage Alzheimer’s and its potentially fatal complications.
July 8, 2023
Hawaii Pacific Neuroscience was one of the sites participating in the clinical trials for the drug Leqembi for people with early Alzheimers disease. Leqembi is the first drug proven to
December 20, 2022
Simple blood tests for Alzheimer's disease have hit the market, representing a potentially powerful tool to help diagnose the devastating illness. But the tests are stirring debate on scientific and ethical questions.
November 19, 2022
New blood tests that can detect abnormal proteins associated with Alzheimer's may change the way the disease is diagnosed, allowing many patients to be tested before they even show symptoms, Laurie McGinley reports for the Washington Post. However, despite the potential benefit of these tests, some health experts caution that more research is needed before they can be used more broadly.
September 29, 2022
A new drug aimed at slowing cognitive decline in patients with early Alzheimer’s disease has proved effective in studies.